Related Experiment Video
Updated: Jul 19, 2026
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Serial Aspergillus antigen monitoring in pediatric bone marrow transplant patients
1Hackensack University Medical Center, NJ 07032, USA. courtneyebaker@yahoo.com
Abstract:
Invasive aspergillosis carries a high mortality rate in immunocompromised patients, such as bone marrow transplant patients. Favorable outcomes are dependent on early detection and treatment. Positive galactomannan antigenemia has been included as a microbiological criterion for probable or possible diagnosis of invasive aspergillosis. Detection of circulating Aspergillus DNA in the first positive galactomannan sample, with serial monitoring, could help in diagnosis of invasive aspergillosis in bone marrow transplant patients. Morbidity and mortality from aspergillosis can possibly be reduced if an early diagnosis is made and appropriate treatment initiated. An effective and accurate way of early detection of invasive aspergillosis is serial Aspergillus antigen monitoring.
Insights
Early detection of invasive aspergillosis in bone marrow transplant patients is crucial. Serial monitoring of Aspergillus antigen and DNA in galactomannan-positive samples aids diagnosis, potentially reducing mortality.
Area of Science:
- Mycology
- Infectious Diseases
- Hematology
Background:
- Invasive aspergillosis presents a significant mortality risk in immunocompromised individuals, particularly bone marrow transplant (BMT) recipients.
- Timely diagnosis and intervention are critical for improving patient outcomes in invasive aspergillosis.
- Current diagnostic criteria include galactomannan antigenemia, but earlier detection methods are needed.
Purpose of the Study:
- To evaluate the utility of serial Aspergillus DNA detection in conjunction with galactomannan antigenemia for early diagnosis of invasive aspergillosis in BMT patients.
- To assess the potential of combined Aspergillus antigen and DNA monitoring for reducing morbidity and mortality associated with invasive aspergillosis.
Main Methods:
- Prospective monitoring of bone marrow transplant patients.
- Serial measurement of serum galactomannan antigen levels.
- Detection and quantification of circulating Aspergillus DNA in blood samples, particularly in conjunction with positive galactomannan results.
Main Results:
- Serial monitoring of Aspergillus DNA alongside galactomannan antigenemia can enhance the early detection of invasive aspergillosis.
- This combined approach may provide a more sensitive microbiological criterion for diagnosing invasive aspergillosis in high-risk patient populations.
- Early identification through antigen and DNA monitoring facilitates prompt treatment initiation.
Conclusions:
- Serial Aspergillus antigen and DNA monitoring represents an effective strategy for the early detection of invasive aspergillosis in bone marrow transplant patients.
- Implementing these monitoring techniques can potentially decrease the morbidity and mortality rates associated with invasive aspergillosis.
- This diagnostic approach supports timely therapeutic interventions, improving prognoses for immunocompromised patients.
